Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy
Matthew E.R. Butchbach(University of Delaware), Mark E. Gurney(California Institute of Technology)
Cited by 119
Related Papers
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes
|Nature Genetics|2007|1.1k
Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US
|Alzheimer s & Dementia|2024|140